Potential Dupilumab‐Induced Unmasking of Specific Immunoglobulin Deficiency: A First‐of‐Its‐Kind Case

Roshani Bista, Debbie Aishwarya Sathya, Sushan Gupta, Danish Thameem · 2026

Read Potential Dupilumab‐Induced Unmasking of Specific Immunoglobulin Deficiency: A First‐of‐Its‐Kind Case by Roshani Bista, Debbie Aishwarya Sathya, Sushan Gupta, Danish Thameem (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13197888.txt.

Description

Bista and co-authors report a case where a common allergy and asthma drug may have exposed a hidden immune defect, in a 2026 case report. The drug, dupilumab, blocks a signal that helps B cells mature and swap antibody types. A 45-year-old woman with severe asthma and sinus disease began the drug after standard therapy failed. A year later she developed a severe chest infection with MRSA bacteria and fluid around the lung.

A second such episode came two years later. Blood tests showed falling antibody levels and a weak response to a pneumonia vaccine, pointing to a specific antibody deficiency. The timing suggests the drug unmasked a defect that had stayed silent. The authors urge awareness of this first reported link.

Catalog record

CREATORRoshani Bista, Debbie Aishwarya Sathya, Sushan Gupta, Danish Thameem
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13197888

Browse the full library · About the Tower of Babel